Request Download Report

View Synopsis & Table of Content
{reportSlug=global-kidney-renal-cancer-drugs-market, reportId=180435, mktKeyword=Kidney Renal Cancer Drugs, cagr=0.00, publishDate=Mar 2024, priceOption2=6800, reportTitle=Kidney Renal Cancer Drugs Comprehensive Study by Type (Anti-angiogenesis therapy, Tyrosine kinase inhibitors (TKIs), MTOR inhibitors), Application (Clear cell renal cell carcinomas (ccRCC), Papillary renal cell carcinoma (PRCC), Chromophobe RCC, Collecting duct RCC, Unclassified RCC, Others), End-User (Hospitals, Cancer Therapy Centers, Home Care Settings) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=218, priceOption1=3650, forecastYr=2030, noOfPages=239, reportKey=179944, breadcrum=Global Kidney Renal Cancer Drugs Market}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Mar 2024 239 Pages 53 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner